The ethics of pay-to-play clinical trials are a minefield. Last week the HHS Secretary’s Advisory Committee on Human Research Protections (SACHRP) stepped into that minefield. Are “pay-to-play” clinical trials ever ethically acceptable?
Search: “how they view us”
We found 3,548 results for your search.
Faye Flam of Bloomberg Technology defended Presidential candidate Marianne Williamson against charges of being antivaccine and antiscience. It does not go well. Flam ignores the worst nonsense and misunderstands science.
This week, JAMA Internal Medicine published a clinical trial purporting to find that acupuncture helps stable angina. Here’s a hint: It doesn’t. It’s a bait-and-switch study that used “electroacupuncture” instead of acupuncture with poor blinding and lack of consideration of prior plausibility.
Antivaxers are going to descend on Washington for their Vaccine Injury Epidemic (VIE) Event in November. Meet the new antivax march, same as the old antivaccine march.
This month the largest epidemiological study of its kind was published and concluded, once again, that autism is primarily due to genes and that the environmental component of autism risk is small. Not surprisingly, once again antivaxers didn’t want to hear that message.
